In the last decade, researchers in academia and the technology sector have been racing to unlock the potential of artificial intelligence. In parallel with federally-funded efforts from the National Institutes of Health and the National Science Foundation, heavy-hitters such as Microsoft, Facebook and Google are deeply invested in artificial intelligence.
As part of the BRAIN Initiative, many University of California, Davis investigators across campus are studying the nervous system and developing new technologies to investigate brain function.
Reverse-engineering the brain is a central tenet to reproducing human intelligence. However, experts say, most efforts to design artificial brains haven’t involved giving much attention to real ones. By understanding how our brains work, we can leverage artificial intelligence to test new drug therapies for brain disorders, and one day even circumvent neurological disorders such as Alzheimer’s disease or Parkinson’s disease… Continue reading.
WASHINGTON, D.C.— The American Institute for Medical and Biological Engineering (AIMBE) has announced the pending induction of Karen Moxon, Ph.D., Professor and Associate Director for Research, School of Biomedical Engineering, Science and Health Systems at Drexel University ; Professor, College of Medicine, Neurobiology and Anatomy, Drexel University College of Medicine, School of Biomedical Engineering, Science and Health Systems, Drexel University, to its College of Fellows. Dr. Moxon was nominated, reviewed, and elected by peers and members of the College of Fellows For contributions to neuroengineering research and the development of neurorobotics.